<p>  </p> <p>Osteoarthritis (OA) is prevalent in equine and can be career-ending for performance horses due to lameness limitations and decreased quality of life. OA is a progressive, multifactorial disease that compromises the synovial joints' normal function, resulting in subchondral bone and articular cartilage deterioration over time. OA is a complex disease that impacts the entire joint, wherein activation of the innate immune system has an essential role in the disease progression and the development of pain. The synovial membrane, or the synovium, is a crucial contributor to the inflammation of diseased joints, regardless of the intra-articular tissue type initially affected. Synoviocytes are a predominant cell type of the synovium and contribute to inflammation by releasing key mediators and degradative enzymes, such as interleukin (IL)-6, IL-1β, a disintegrin, and metalloproteinase (ADAM) domains, and matrix metalloproteinases (MMPs). The production of pro-inflammatory molecules sequentially influences the expression of degradative enzymes and cartilage destruction. Therefore, the pathophysiological processes within synovial joints afflicted by OA can be further understood by studying the characteristics of synoviocytes.</p> <p>We aimed to investigate the inflammatory component of OA in an <em>in vitro</em> model using a primary cell line of equine fibroblast-like synoviocytes (eqFLS) stimulated with tumor necrosis factor-alpha (TNF-α) to represent an initial inflammatory stimulus. Our studies have shown that stimulating eqFLS with TNF-α for 24 hours significantly increased the gene expression of pro-inflammatory biomarkers. Among several pro-inflammatory candidate genes assayed, only pro-inflammatory cytokine IL-6 gene expression could be detected reproducibly following stimulation with the TNF-α gene in eqFLS. We characterized the pro-inflammatory response of eqFLS and utilized this system to examine the impact of novel therapeutic compounds designed <em>in-silico</em> with the goal of reducing the inflammatory response of eqFLS. A piperazine-based compound (C3) and its derivative (02-09) were primarily designed to mimic the interactions of the growth factor pigment epithelium-derived factor (PEDF) with its receptor, the non-integrin laminin receptor 1 (LAMR1). Based on previous <em>in vitro</em> studies in the laboratory, C3 and 02-09 had been proposed to have a strong potential for inhibiting inflammation while reducing angiogenesis and chondrocyte hypertrophy. The efficacy of these two novel compounds on eqFLS was examined in the present work by assessing the gene expression levels of inflammatory biomarkers, including IL-6, IL-1β, IL-8, ADAMs, and MMPs relative to a control housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in various study designs. An <em>in-vitro</em> screen with the IL-1β promoter driving a reporter green fluorescent protein (GFP) was also designed to detect and track the inflammatory response of eqFLS by imaging following stimulation with or without (+/-) TNF-α relative to controls. This screen will be utilized in future studies to potentially identify more effective compounds in the LAMR1-interacting series. The current findings suggest that the novel compounds, especially 02-09, might exhibit an anti-inflammatory effect on eqFLS; therefore, it is a potential therapeutic agent in modulating inflammation during OA development. </p> <p><br></p>

No description available.

Made available in DSpace on 2016-08-10T10:38:42Z (GMT). No. of bitstreams: 1 CELINA KASSUMI KUNIEDA SUZUKI.pdf: 2013145 bytes, checksum: c807ebe49c872194bb7af7cd6bb5d17f (MD5) Previous issue date: 2012-06-29 / The increased prevalence of childhood obesity in recent years suggests the existence of a genetic predisposition or susceptibility to conditioning factors for obesity which act on the environmental factors related to lifestyle involving diet and physical activity. Food education programs and physical activities have been developed in order to reverse this situation. The chewing is considered one of the early stages of the digestive process and therefore primordial important because performing correctly promotes natural hunger satiety as well as a healthy digestion. The aim of this study is to investigate the polymorphism of the TNF-&#945; and DRD2 genes and the influence of masticatory profile in childhood obesity to enable the preparation of proposals for more effective interventions to control weight gain. For this purpose the study has been divided into two articles. ARTICLE 1: This study evaluated the profile of the obese child chewing through survey and evaluation of clinical history miofunctional from the protocols of MgBr and AMIOFE-A (attached) in 11 normal children representing the control population (Group I) and 16 obese children (Group B) participating in the CAIS Group of Obesity in Goiânia Municipal and School of Clinical Speech Therapy PUC Goiás aged between 6 and 13 years for both sexes. According to the findings obtained in the research, it is concluded that obese group (OB) presents an incision chewing food made with the central and lateral incisors with the majority labial sealing with or without excessive movement, unilateral pattern, with higher presence of altered behaviors in chewing and shorter chewing time. ARTICLE 2: This study evaluated the genetic polymorphism of TNF-&#945; gene (G308A) and DRD2 (Taq1&#945; - C32806T) in 27 patients with childhood obesity (16) and controls (11) using the method ARMS-PCR and PCR-RFLP, respectively, in peripheral blood samples. The results suggest that the genetic polymorphism of Taq1&#945; (C32806T) in the DRD2 gene was associated with the increase of obesity in the childhood. Still genetic variants of the SNP G308A TNF-&#945; gene is not possible to confirm it s influence on children s weight gain. Understanding how genetic variations affect the tendency to become or remain obese is an important step to comprehend the mechanisms that lead to obesity. / O aumento da prevalência da obesidade infantil nestes últimos anos sugere a existência de predisposição ou suscetibilidade genética como fatores condicionantes para a obesidade, sobre a qual atuam fatores ambientais relacionados ao estilo de vida, que envolvem hábitos alimentares e atividade física. Programas de educação alimentar e de atividades físicas foram desenvolvidos visando reverter este quadro. A mastigação é considerada uma das fases iniciais do processo digestório e de primordial importância, pois quando realizada de forma correta, promove a saciedade natural da fome, bem como uma digestão saudável. O objetivo deste estudo foi investigar o polimorfismo dos genes TNF-&#945; e DRD2 e a influência da mastigação na obesidade infantil para possibilitar a elaboração de propostas de intervenções mais eficazes para o controle do ganho de peso Para esta finalidade, o estudo foi dividido em dois artigos. ARTIGO 1: Este estudo avaliou o perfil mastigatório da criança obesa, por meio de levantamento de histórico clínico e avaliação miofuncional orofacial a partir dos protocolos do MGBR e AMIOFE-A (anexos), em 11 crianças eutróficas representando a população controle (Grupo EU) e 16 crianças obesas (Grupo OB) participantes de Grupo de Obesidade dos CAIS Municipais da cidade de Goiânia e da Clínica- Escola de Fonoaudiologia da PUC Goiás, com idade entre 6 e 13 anos de ambos os sexos. Conforme os achados obtidos na pesquisa, conclui-se que o grupo obeso (OB) apresenta uma mastigação com incisão do alimento feito com os incisivos centrais e laterais, sendo a maioria com vedamento labial sem ou com movimentação excessiva, padrão unilateral, com maior presença de comportamentos alterados na mastigação e tempo de mastigação reduzido. ARTIGO 2: Este estudo avaliou o polimorfismo genético dos genes TNF-&#945; (G308A) e DRD2 (Taq1&#945; - C32806T) em 27 pacientes com obesidade infantil (16) e de controle (11), utilizando o método de ARMS-PCR e PCR-RFLP, respectivamente, em amostras do sangue periférico. Os resultados sugerem que o polimorfismo genético em Taq1&#945; (C32806T) no gene DRD2 apresentou associação com o incremento na obesidade infantil. Por outro lado, as variantes genéticas do SNP G308A do gene TNF-&#945; não permitiram confirmar sua participação no ganho de peso em crianças. Entender como variações genéticas afetam a obesidade consiste em um passo importante na compreensão dos mecanismos desencadeadores da obesidade.

Submitted by Luciana Ferreira (lucgeral@gmail.com) on 2017-01-17T11:14:30Z No. of bitstreams: 2 Dissertação - Barbara Hess Rodrigues Gonçalves - 2016.pdf: 1742093 bytes, checksum: 80bd9955d0b421c59b1e6faf6d41f773 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2017-01-17T11:14:56Z (GMT) No. of bitstreams: 2 Dissertação - Barbara Hess Rodrigues Gonçalves - 2016.pdf: 1742093 bytes, checksum: 80bd9955d0b421c59b1e6faf6d41f773 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2017-01-17T11:14:56Z (GMT). No. of bitstreams: 2 Dissertação - Barbara Hess Rodrigues Gonçalves - 2016.pdf: 1742093 bytes, checksum: 80bd9955d0b421c59b1e6faf6d41f773 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2016-12-13 / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / Canine atopic dermatitis (CAD) is the second most frequent disease in dermatological clinical routine of dogs. It is defined as a pruritic allergic skin disease, with genetic predisposition and clinical features, being related to the response to environmental allergens. Interleukin 31 (IL) 31 is a cytokine that participates in inflammatory processes and it is associated with pruritic diseases, especially those involving chronic inflammation such as allergic dermatitis. Produced by mononuclear cells, IL-31 is described to play an important role in the pathogenesis of atopic dermatitis. Two studies were performed in order to correlate clinical features, histopathological changes and the presence of IL-31 in the skin of dogs with atopic dermatitis. 34 dogs were selected from clinical routine, which 31 animals were diagnosed with CAD and three were healthy. The animals were evaluated for pruritus level by the owners' report and by clinical examination according to the CAD extent and severity index (CADESI-4). The dogs were grouped in discreetly, moderately and markedly compromised by CAD following the sum of scores’ values assigned in the clinical examination. Cutaneous samples from the axillary and interdigital regions of each dog were collected and submitted to histopathological (HE and toluidine blue) and immunohistochemical analyzes (IL-31). There was a correlation between the clinical score and the microscopic changes. As well, there was correlation among all the microscopic changes, but not between the degree of pruritus and the clinical score of CAD. Also, the inflammatory infiltrate was more intense in the axillary region in relation to interdigital skin. An increased numbers of cells immunostained for IL-31 was observed in dogs severely compromised by CAD. There was a correlation between the clinical score and the amount of interdigital mast cells, with an amount of cells immunostained for IL-31 in the axilla. It was also verified correlation between the amount of mast cells and cells immunostained for IL-31 in the axilla, as well as between acanthosis and all other histopathological alterations of the skin in the axillary region. We concluded that there is a correlation between severity of dermathological lesions, IL-31 immunostaining, mast cell count and histopathological changes in dogs with atopic dermatitis, but there is no correlation between the degree of pruritus reported by owners and severity of cutaneous lesions in animals with CAD. Moreover, the intensity of the inflammatory process may vary depending on the anatomical site of the lesion. / A dermatite atópica canina (DAC) é a segunda doença mais incidente na rotina de atendimento clínico dermatológico de cães. É definida como doença cutânea alérgica pruriginosa, de predisposição genética e características clínicas definidas, estando relacionada a resposta a alérgenos ambientais. A interleucina 31 (IL) 31 é uma citocina que participa de processos inflamatórios e está associada a doenças pruriginosas, principalmente as que envolvem inflamação crônica como as dermatites alérgicas. Produzida por células mononucleares, a IL-31 é descrita por desempenhar papel importante na patogênese da dermatite atópica.Com o objetivo de correlacionar as alterações clínicas, histopatológicas e a presença da IL-31 na pele de cães com dermatite atópica foram realizados dois estudos. Para isso, foram selecionados 34 cães da rotina de atendimento clínico, sendo 31 com diagnóstico de DAC e três hígidos. Os animais foram avaliados quanto ao nível de prurido a partir do relato de seus proprietários e quanto ao índice de extensão e severidade da DAC (CADESI-4) a partir do exame clínico. Os cães foram agrupados em discretamente, moderadamente e acentuadamente comprometidos pela DAC após somatório dos valores de escores atribuídos no exame clínico. Amostras cutâneas da região axilar e interdigital de cada cão foram colhidas e submetidas às análises histopatológica (HE e azul de toluidina) e imunoistoquímica (IL-31). Houve correlação entre o escore clínico e as alterações microscópicas, assim como entre as alterações microscópicas, mas não entre o grau de prurido e o escore clínico da DAC. Também o infiltrado inflamatório foi mais intenso na região axilar em relação a interdigital. Maior número de células imunomarcadas para IL-31 foi observado nos cães acentuadamente comprometidos pela DAC. Houve correlação entre o escore clínico e a quantidade de mastócitos no interdígito, do mesmo modo com a quantidade de células imunomarcadas para IL31 na axila. Também foi verificada correlação entre a quantidade de mastócitos e células imunomarcadas para IL-31 na axila, assim como entre acantose e todas as demais alterações histopatológicas da pele na região axilar. Conclui-se que há correlação entre a gravidade das lesões, a imunomarcação de IL-31, a contagem de mastócitos e as alterações histopatológicas em cães com dermatite atópica, mas não há correlação entre o grau de prurido relatado pelos proprietários e a gravidade das lesões cutâneas em animais com DAC. Ainda, a intensidade do processo inflamatório pode variar em função do sítio anatômico da lesão.

Les douleurs neuropathiques désignent une hypersensibilité du système nerveux central sensoriel. C’est une maladie chronique et handicapante qui touche environ 6% de la population française. Cependant, à l’heure actuelle, il n’existe pas de traitement spécifique et efficace. Dans le cadre de cette thèse, nous avons utilisé deux stratégies différentes afin de développer des outils pharmacologiques originaux pour traiter ces douleurs : une approche phénotypique autour de deux inhibiteurs de la surproduction de TNFα (un dérivé de 2-aminopyrimidine et un dérivé de pyridin-2-yl guanidine) et une approche moléculaire autour du MY 5445 (un inhibiteur de PDE5 dérivé de phtalazine). En particulier, notre travail s’est basé sur la conception, la synthèse et l’étude des relations structure-activité autour de ces différents hits et nous avons obtenu des composés efficaces par voie i.p. ou per-os sur un modèle murin de douleurs neuropathiques.En parallèle de ce travail de pharmacologie, nous avons développé différents systèmes catalytiques (Pd, Cu) en milieu micellaire afin de former des liaisons C-N à température quasi-ambiante. / Neuropathic pains correspond to a central sensory nervous system hypersensitivity. It is a chronic and disabling disease, which touch around 6% of the French population. Nowadays, there is no specific and efficient treatment. In my PhD project, we used two different strategies in order to develop innovative pharmacological tools to treat those pains: a phenotypic approach around two TNFα overproduction inhibitor (a 2-aminopyrimidine derivative and a pyridin-2-yl guanidine derivative) and a molecular approach around MY 5445 (a phthalazine PDE5 inhibitor). Our work was based on the design, synthesis and structure-activity relationship study around various hits and we obtained compounds i.p. and orally effective on a murin neuropathic pain model.In parallel to this pharmacological work, we developed different catalytic systems (Pd, Cu) under micellar conditions to form C-N bonds at almost room temperature.